Jan Krutzfeldt studies the role of insulin receptors in pancreatic beta cells, which are responsible for producing insulin, a hormone that helps control blood sugar levels. In particular, he investigates how the absence of these receptors affects the cells' ability to sense sugar and produce insulin, which can lead to high blood sugar levels. His work uses mouse models to delve into the biological processes that underlie these mechanisms, aiming to uncover new insights into diabetes and possible therapeutic approaches.
Key findings
In a study involving betaIRKO mice, 25% of the mice failed to produce adequate insulin, resulting in elevated blood sugar levels.
The research revealed that insulin receptors on beta cells are crucial for their growth and proper functionality, rather than just for the body's response to insulin.
The beta cells in these mice had significantly reduced mass, indicating that damaged insulin signaling can lead to structural and functional failings in insulin production.
Frequently asked questions
Does Jan Krutzfeldt study diabetes?
Yes, he specifically researches the mechanisms behind insulin production and regulation, which are directly related to diabetes.
What treatments has Jan Krutzfeldt researched for diabetes?
While his studies primarily focus on basic mechanisms, understanding insulin receptor function may help identify new treatment targets for diabetes.
Is Jan Krutzfeldt's work relevant to patients with high blood sugar?
Absolutely, his research looks at the underlying causes of inadequate insulin secretion, which is central to many cases of high blood sugar and diabetes.
Publications in plain English
Single Center, Open-Label, Randomized Crossover Trial on Drug-Drug Interactions of Levothyroxine/Magnesium-Citrate and Levothyroxine/Magnesium-Aspartate in Healthy Subjects-The ThyroMag Trial.
2025
Clinical and translational science
Attinger MC, von Felten S, Rodrigues CL, Krützfeldt J, Risch L +1 more
Plain English This study looked at how two types of magnesium—magnesium aspartate and magnesium citrate—affect the absorption of a thyroid medication called levothyroxine in 15 healthy adults. Researchers found that taking magnesium aspartate with levothyroxine reduced the medication's absorption by 12%, while magnesium citrate decreased it by 7%. This is important because it shows that magnesium can interfere with how well levothyroxine works, which is crucial for people with thyroid issues to manage their hormone levels effectively.
Who this helps: This helps patients with thyroid conditions who need to take levothyroxine.
Clinical predictors of negative/equivocal SPECT imaging outcomes in primary hyperparathyroidism: Factors calling forF-choline-PET.
2024
American journal of otolaryngology
Ferrari SB, Morand GB, Rupp NJ, Krützfeldt J, Vetter D +2 more
Plain English This research focused on finding out which factors make SPECT imaging less effective in detecting parathyroid adenomas in patients with primary hyperparathyroidism. The study analyzed 138 patients and found that SPECT scans only successfully identified the adenomas about 49% of the time, while F-choline-PET scans were much more reliable, detecting adenomas 97% of the time. Knowing which patients are likely to have negative SPECT results can help doctors decide when to use the more accurate F-choline-PET imaging, leading to better treatment decisions.
Who this helps: This helps patients with primary hyperparathyroidism who need accurate diagnosis and treatment.
Prospective Study of Ageing Trajectories in the European DO-HEALTH Study.
2023
Gerontology
Ghisla V, Chocano-Bedoya PO, Orav EJ, Abderhalden LA, Sadlon A +5 more
Plain English This research studied how older adults in Europe transition between different health states as they age. They found that out of nearly 1,900 participants, 23.1% were initially considered healthy, but over time, only 12.0% improved their health status while 22.8% became less healthy. It matters because it highlights that as people age, especially women, the chance of improving health declines, which can inform health care and support for aging populations.
Who this helps: This helps older adults and doctors working on aging-related health issues.
Activation of PDGF Signaling in the Adult Muscle Stem Cell Niche in Patients With Type 2 Diabetes Mellitus.
2023
The Journal of clinical endocrinology and metabolism
Fahrner A, Alchus Laiferová N, Ukropcová B, Ukropec J, Krützfeldt J
Plain English This research studied how type 2 diabetes affects muscle stem cells by looking at specific markers in muscle tissue from patients with the disease. The findings showed that levels of a signaling protein called PDGF and its related markers were significantly higher in patients with type 2 diabetes—up to 2.85 times more than in people without diabetes, highlighting changes in the muscle environment that may harm muscle health. Understanding this signaling pathway is important because it could help doctors develop better treatments to improve muscle function and glucose management for diabetes patients.
Who this helps: Patients with type 2 diabetes.
microRNA-501 controls myogenin/CD74myogenic progenitor cells during muscle regeneration.
2023
Molecular metabolism
Fahrner A, Luca E, Krützfeldt J
Plain English This study looked at how a small molecule called microRNA-501 affects muscle repair in younger and older mice. Researchers found that older mice had a lower number of certain muscle cells important for regeneration, and these cells produced less of a protein that helps repair muscles. In knockout mice (which had the microRNA-501 removed), muscle regeneration was better even as they aged, showing that targeting microRNA-501 could improve muscle recovery in older individuals.
Who this helps: This benefits older patients who struggle with muscle regeneration.
Altered Distribution of Unesterified Cholesterol among Lipoprotein Subfractions of Patients with Diabetes Mellitus Type 2.
2023
Biomolecules
Kolb LN, Othman A, Rohrer L, Krützfeldt J, von Eckardstein A
Plain English This study looked at the cholesterol levels in different types of fats in the blood of people with type 2 diabetes compared to healthy individuals. They analyzed blood samples from 66 diabetic patients and 51 healthy volunteers, finding that people with diabetes had lower levels of free cholesterol in most cholesterol particles, except small HDL, while their very low-density lipoproteins (VLDL) contained higher cholesterol levels. These findings are important because they could help doctors better understand cholesterol imbalances in diabetic patients and manage their risk for complications.
Who this helps: This benefits patients with type 2 diabetes and their healthcare providers.
Plain English This study examined the common hormonal reasons behind excessive sweating, a problem many people do not mention unless asked. Researchers found that menopause and hyperthyroidism are the most frequent causes, while low testosterone in older men is rarer and often linked to sexual issues. Understanding these causes is important for proper diagnosis and treatment, helping to improve quality of life for those affected.
Who this helps: This helps patients dealing with excessive sweating and their doctors in diagnosing and treating the condition effectively.
Growth hormone/IGF-I-dependent signaling restores decreased expression of the myokine SPARC in aged skeletal muscle.
2022
Journal of molecular medicine (Berlin, Germany)
Mathes S, Fahrner A, Luca E, Krützfeldt J
Plain English This study looked at how growth hormone (GH) and a related protein called IGF-I affect the levels of a muscle protein called SPARC in older muscles. Researchers found that giving GH increased SPARC levels in aged mice by 3.5 times, and that IGF-I directly activates SPARC production in muscle cells. Understanding how these proteins influence muscle health is important because it might lead to new treatments to reduce fat buildup in muscles as people age.
Who this helps: This helps older patients looking to maintain healthy muscle function.
FGF-2-dependent signaling activated in aged human skeletal muscle promotes intramuscular adipogenesis.
2021
Proceedings of the National Academy of Sciences of the United States of America
Mathes S, Fahrner A, Ghoshdastider U, Rüdiger HA, Leunig M +2 more
Plain English This study examined how a specific protein called FGF-2 affects muscle growth and fat buildup in older muscles. Researchers found that FGF-2 not only helps muscles grow but also encourages fat cells to form within the muscles, especially in people over 75, who showed increased fat accumulation compared to those under 55. Understanding this process is important because it may lead to new methods for reducing unhealthy fat buildup in the muscles of older adults, which can impact their mobility and overall health.
Who this helps: Older adults seeking to maintain muscle health and mobility.
Plain English This study focused on analyzing the different proteins found in high-density lipoprotein (HDL), which is known as "good cholesterol." Researchers examined blood samples from over 300 patients to create detailed libraries that help identify variations in HDL proteins between healthy people and those with diabetes or heart disease. They found that they could detect significant differences in the HDL proteins, which may help understand how conditions like diabetes affect heart health.
Who this helps: This benefits patients with diabetes and heart disease, as well as their doctors.
Structure-function relationships of HDL in diabetes and coronary heart disease.
2020
JCI insight
Cardner M, Yalcinkaya M, Goetze S, Luca E, Balaz M +20 more
Plain English This study looked at how high-density lipoproteins (HDL), which are important for heart and metabolic health, differ in people who are healthy compared to those with diabetes or heart disease. Researchers examined the HDL from 51 healthy individuals and 98 patients with either diabetes or coronary heart disease and found that these conditions caused distinct changes in HDL's structure and function. They also identified three new factors that affect HDL's ability to support cell health, which can help in understanding how to improve treatments for these diseases.
Who this helps: This research benefits patients with diabetes and coronary heart disease by guiding better treatment strategies.
Genetic deletion of microRNA biogenesis in muscle cells reveals a hierarchical non-clustered network that controls focal adhesion signaling during muscle regeneration.
2020
Molecular metabolism
Luca E, Turcekova K, Hartung A, Mathes S, Rehrauer H +1 more
Plain English This study looked at how certain microRNAs (small molecules that help control gene activity) affect muscle regeneration, especially in aging. Researchers found a network of microRNAs that regulate important muscle functions, discovering that combining different miRNA inhibitors led to improved muscle growth and repair in mice, specifically showing increased muscle mass and fiber formation after injury. This is important because it could lead to new treatments for age-related muscle loss.
Who this helps: Patients experiencing muscle loss due to aging.
Relating ocean temperatures to frontal ablation rates at Svalbard tidewater glaciers: Insights from glacier proximal datasets.
2019
Scientific reports
Holmes FA, Kirchner N, Kuttenkeuler J, Krützfeldt J, Noormets R
Plain English This study looked at how ocean temperatures affect the melting and breaking off of ice at two glaciers in Svalbard. Researchers found that ocean temperatures significantly influence about 50% of the ice loss at the glacier fronts, but this impact is less than what was found in earlier studies. Understanding how warmer ocean water contributes to glacier melting is important because it helps us grasp the speed at which glaciers are losing ice and how this affects global sea levels.
Who this helps: This helps scientists, policymakers, and climate researchers.
Uncoupling protein 1 expression in adipocytes derived from skeletal muscle fibro/adipogenic progenitors is under genetic and hormonal control.
2018
Journal of cachexia, sarcopenia and muscle
Gorski T, Mathes S, Krützfeldt J
Plain English Researchers studied how certain cells in muscle tissue can change into fat cells that mimic brown fat, which is known for its beneficial effect on metabolism. They found that a specific type of cell called fibro/adipogenic progenitors (FAPs) from muscles can turn into brown-like fat cells, producing a protein called Ucp1, particularly when stimulated by certain hormones. This change was particularly evident in a mouse strain resistant to obesity, showing that genetic and hormonal factors significantly influence this process.
Who this helps: This research helps patients dealing with obesity-related metabolic issues by identifying potential targets for treatments that could improve their muscle health.
MicroRNA-29a in Adult Muscle Stem Cells Controls Skeletal Muscle Regeneration During Injury and Exercise Downstream of Fibroblast Growth Factor-2.
2016
Stem cells (Dayton, Ohio)
Galimov A, Merry TL, Luca E, Rushing EJ, Mizbani A +5 more
Plain English This study looked at how a small molecule called microRNA-29a helps muscle cells regenerate after injury or exercise. Researchers found that when a growth factor called FGF2 is activated, it increases levels of microRNA-29a, which plays a key role in helping muscle stem cells grow and multiply. Specifically, they noted that blocking microRNA-29a slowed down muscle cell growth after injury and exercise.
Who this helps: This benefits patients with muscle injuries and conditions that affect muscle regeneration, especially the elderly.
MicroRNA deep sequencing in two adult stem cell populations identifies miR-501 as a novel regulator of myosin heavy chain during muscle regeneration.
2016
Development (Cambridge, England)
Mizbani A, Luca E, Rushing EJ, Krützfeldt J
Plain English This study focused on a small, specific type of RNA called microRNA, which helps control the regeneration of skeletal muscle. Researchers found that a microRNA named miR-501 was crucial during muscle recovery after injury, as blocking it reduced the formation of important muscle proteins and led to smaller muscle fibers. This discovery is important because it not only sheds light on how muscles heal but also suggests that miR-501 could be a potential marker in the blood to assess muscle regeneration in patients.
Who this helps: This helps patients recovering from muscle injuries and doctors monitoring their healing process.
Strategies to use microRNAs as therapeutic targets.
2016
Best practice & research. Clinical endocrinology & metabolism
Krützfeldt J
Plain English This study focused on the role of microRNAs (miRNAs) in disease and how they can be used as targets for new therapies. Researchers found that miRNAs can either suppress or enhance gene activity depending on their levels, which means that both increasing and decreasing specific miRNAs could be useful in treating diseases like cancer. The findings suggest that using miRNAs effectively could lead to new, personalized treatments, but more research is needed to understand potential side effects and how to deliver these therapies safely.
Who this helps: This helps patients with diseases like cancer or metabolic disorders.
Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study.
2015
Journal of inherited metabolic disease
Hochuli M, Christ E, Meienberg F, Lehmann R, Krützfeldt J +1 more
Plain English This study looked at how different nighttime foods affect blood sugar levels in adults with glycogen storage disease type I (GSDI). Researchers tested three options: uncooked corn starch, modified corn starch, and cooked pasta, finding that pasta was just as effective in keeping blood sugar stable overnight, lasting over 7 hours of healthy glucose levels, similar to the other foods. This is important because it offers a more enjoyable and practical food option for patients managing their condition.
Who this helps: This helps patients with glycogen storage disease type I.
Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance.
2015
Journal of molecular medicine (Berlin, Germany)
Galimov A, Hartung A, Trepp R, Mader A, Flück M +4 more
Plain English This study looked at how growth hormone replacement therapy (GHRT) affects muscle tissue in people with growth hormone deficiency. Researchers found that GHRT reduced levels of a small molecule called miR-29a in muscles, which is important because lower miR-29a was linked to insulin resistance in patients. Specifically, after four months of GHRT, patients showed higher IGF1 levels and a decrease in miR-29a, which contributed to poorer insulin response.
Who this helps: This research benefits patients with growth hormone deficiency who are undergoing GH replacement therapy.
Arylhydrocarbon receptor-dependent mIndy (Slc13a5) induction as possible contributor to benzo[a]pyrene-induced lipid accumulation in hepatocytes.
2015
Toxicology
Neuschäfer-Rube F, Schraplau A, Schewe B, Lieske S, Krützfeldt JM +4 more
Plain English This study focused on how a specific gene (mINDY) is affected by a chemical (benzo[a]pyrene), which may lead to fat build-up in liver cells. Researchers found that exposure to benzo[a]pyrene increased mINDY expression in liver cells, leading to more citrate being taken in and turned into fat. This process could play a role in the development of fatty liver disease, which is a concern for many people worldwide.
Who this helps: This research benefits patients at risk of developing fatty liver disease.
MicroRNA-194 is a target of transcription factor 1 (Tcf1, HNF1α) in adult liver and controls expression of frizzled-6.
2012
Hepatology (Baltimore, Md.)
Krützfeldt J, Rösch N, Hausser J, Manoharan M, Zavolan M +1 more
Plain English This study looked at a specific molecule, called microRNA-194, and its role in the liver, especially how it is controlled by a protein named Tcf1. The researchers found that when Tcf1 was removed from adult mice, levels of microRNA-194 dropped significantly in the liver, leading to an increase in a target molecule called frizzled-6. This matters because it helps us understand how changes in these molecules may play a role in liver cancer development.
Who this helps: This helps researchers and doctors working on liver diseases and cancer treatment.
Plain English This paper studies hyperthyreosis, which is an overactive thyroid condition, and how it is diagnosed and treated. It highlights that the most common causes of hyperthyreosis are Graves disease, which often occurs between ages 35 and 60, affecting about 10-20% of patients with eye-related symptoms, and toxic adenomas that are identified through specific imaging tests. Understanding these conditions and their treatments is important because they are common and can impact patients' overall health and quality of life.
Who this helps: This helps patients with hyperthyreosis and their healthcare providers.
Regulation of wingless-type MMTV integration site family (WNT) signalling in pancreatic islets from wild-type and obese mice.
2010
Diabetologia
Krützfeldt J, Stoffel M
Plain English This study looked at a signaling pathway called WNT in the pancreas of normal and obese mice to see if it plays a role in type 2 diabetes. Researchers found that the WNT signaling was not active in the adult pancreas of either type of mice, but they discovered that the WNT4 molecule was present and increased in obese mice, which actually reduced WNT signaling further. This matters because understanding how WNT signaling is regulated could help in developing treatments for those with type 2 diabetes.
Who this helps: This helps patients with type 2 diabetes and obesity.
Plain English This study looked at a type of RNA, called antagomirs, that can block the activity of other small RNA molecules known as microRNAs (miRNAs) in mice. The researchers found that antagomirs worked best when they were longer than 19 letters and could even tell the difference between similar target miRNAs. They discovered that while antagomirs can't effectively target miRNAs in the brain when given through the bloodstream, they can successfully do so when injected directly into a specific brain area.
Who this helps: This benefits researchers and doctors looking to develop targeted RNA therapies for various diseases.
Strategies to determine the biological function of microRNAs.
2006
Nature genetics
Krützfeldt J, Poy MN, Stoffel M
Plain English This study looked at microRNAs (miRNAs), which are tiny molecules that help control how genes work and play important roles in various biological processes. The researchers found that new tools and methods can improve how scientists identify and study miRNAs, making it easier to understand their roles in health and disease. This is important because gaining insights into miRNAs could lead to new treatments for various illnesses.
Who this helps: This benefits researchers and doctors working on new therapies for patients.
MicroRNAs: a new class of regulatory genes affecting metabolism.
2006
Cell metabolism
Krützfeldt J, Stoffel M
Plain English This research looked at a group of tiny molecules called microRNAs (miRNAs) that help control gene activity and how they impact metabolism. The study found that miRNAs play a significant role in important metabolic processes, particularly in fat cells and muscles, and are involved in managing essential nutrients like fats, proteins, and sugars. Understanding these molecules could lead to new treatments for common metabolic diseases like diabetes and obesity.
Who this helps: This helps patients with metabolic disorders and healthcare providers looking for new treatment options.
Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T +2 more
Plain English The study looked at a new method called "antagomirs" that can shut down specific microRNAs (miRNAs) in mice. When researchers used antagomirs targeting certain miRNAs, they found significant reductions in those miRNAs across various organs, leading to lower cholesterol levels in the blood of mice treated with an antagomir for miR-122. This is important because it shows that antagomirs can effectively control specific miRNAs, offering a potential new approach to treat diseases linked to miRNA imbalances.
Who this helps: Patients with diseases caused by high cholesterol or other miRNA-related issues.
Tmem27: a cleaved and shed plasma membrane protein that stimulates pancreatic beta cell proliferation.
2005
Cell metabolism
Akpinar P, Kuwajima S, Krützfeldt J, Stoffel M
Plain English This study looked at a protein called Tmem27 that plays a key role in the growth of insulin-producing cells in the pancreas. Researchers found that when they increased Tmem27 levels in mouse models, the number of beta cells increased significantly. For instance, in engineered mice with more Tmem27, the mass of these cells grew larger, which is crucial since a healthy amount of beta cells is essential for insulin production and overall blood sugar control.
Who this helps: This benefits patients with diabetes, as finding ways to boost beta cell growth could lead to better treatments.
A pancreatic islet-specific microRNA regulates insulin secretion.
2004
Nature
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X +6 more
Plain English This study focused on a specific microRNA called miR-375, which is found in pancreatic cells that produce insulin. Researchers discovered that increasing miR-375 levels reduced insulin secretion in response to glucose, while blocking its function increased insulin secretion. This finding highlights the role of miR-375 in regulating insulin release, making it a potential new target for diabetes treatments.
Who this helps: This benefits patients with diabetes who need better ways to manage their insulin levels.
Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice.
2004
American journal of physiology. Endocrinology and metabolism
Otani K, Kulkarni RN, Baldwin AC, Krutzfeldt J, Ueki K +3 more
Plain English Researchers created mice without working insulin receptors on their pancreatic beta cells (the cells that make insulin) and found that these mice couldn't make enough insulin, causing high blood sugar in about a quarter of them. The main problem was that their beta cells didn't grow properly after birth and had difficulty sensing glucose levels, which prevented them from releasing insulin when needed. This discovery shows that insulin receptors on beta cells themselves are necessary for the cells to grow and function correctly—not just for other tissues to respond to insulin.
Skeletal muscle cells from insulin-resistant (non-diabetic) individuals are susceptible to insulin desensitization by palmitate.
2003
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Kausch C, Staiger H, Staiger K, Krützfeldt J, Matthaei S +2 more
Plain English This study looked at how fatty acids affect insulin action in muscle cells from people who are insulin-resistant and those who are insulin-sensitive. Researchers found that when muscle cells from insulin-resistant individuals were treated with palmitate (a type of fatty acid), insulin's ability to help store sugar decreased by 27%, while insulin-sensitive cells showed no such decline. This is important because it suggests that insulin resistance in these individuals may be due to their muscle cells being more easily affected by certain fats rather than problems with how insulin itself works.
Who this helps: This benefits patients dealing with insulin resistance, especially those at risk of developing diabetes.
The Protein-tyrosine-phosphatase SHP2 is phosphorylated on serine residues 576 and 591 by protein kinase C isoforms alpha, beta 1, beta 2, and eta.
2002
Biochemistry
Strack V, Krützfeldt J, Kellerer M, Ullrich A, Lammers R +1 more
Plain English This study examined how certain enzymes, called protein kinase C (PKC) isoforms, interact with a protein known as SHP2, which is important for insulin signaling in cells. Researchers found that PKC isoforms can specifically add a chemical tag (phosphorylation) to SHP2 at two locations, called serine 576 and 591, but this tagging does not affect the protein's activity in the way they tested. It matters because understanding this interaction could help improve treatments for conditions related to insulin signaling, like diabetes.
Who this helps: Patients with diabetes and related metabolic disorders.
Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
2001
Biochemical and biophysical research communications
Kausch C, Krützfeldt J, Witke A, Rettig A, Bachmann O +5 more
Plain English This study looked at how a drug called troglitazone affects human muscle cells. The researchers found that when muscle cells were treated with troglitazone for a longer period, they stopped developing properly and instead started acting like fat cells, with muscle cell markers decreasing and fat cell markers increasing. Additionally, the treated cells showed a significant increase in glucose uptake and insulin activity, roughly 1.6 times and 2.5 times greater than untreated cells.
Who this helps: This research helps doctors understand how certain diabetes medications impact muscle cells, which can improve treatment strategies for patients with insulin resistance.
Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms beta2 and theta.
2000
Diabetologia
Strack V, Hennige AM, Krützfeldt J, Bossenmaier B, Klein HH +3 more
Plain English This study looked at specific parts of the insulin receptor and how they influence insulin signaling, which is crucial for controlling blood sugar levels. Researchers found that changes to two serine residues (positions 994 and 1023/25) in the receptor made it less likely to be inhibited by certain proteins called kinase types beta2 and theta. Specifically, these mutations led to a 55-58% reduction in the normal inhibitory response, which is significant because it highlights how these specific serine residues play a key role in insulin signaling.
Who this helps: This research benefits patients with insulin resistance or diabetes by informing potential new treatments.
Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation.
2000
Diabetes
Bossenmaier B, Strack V, Stoyanov B, Krützfeldt J, Beck A +6 more
Plain English In this study, researchers examined specific parts of the insulin receptor by changing certain serine amino acids to alanine and observing how this affected insulin signaling in cells. They found that a mutation affecting serines 1177, 1178, and 1182 reduced the phosphorylation of important signaling proteins, even though the insulin receptor could still self-phosphorylate normally. This is important because it reveals a critical area that regulates insulin action in the body, which could lead to better understanding and treatment of insulin-related conditions like diabetes.
Who this helps: This helps patients with insulin resistance and diabetes by providing insights that could lead to improved treatments.
Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity.
2000
Diabetes
Krützfeldt J, Kausch C, Volk A, Klein HH, Rett K +2 more
Plain English This study looked at how insulin works in muscle cells taken from lean individuals who are either insulin-resistant or insulin-sensitive. The researchers found that there were no significant differences in how the muscle cells responded to insulin when it came to taking up glucose or making glycogen, even though the two groups had different overall insulin sensitivities. These findings suggest that factors outside the muscle cells, rather than the cells themselves, might be important in how insulin resistance develops.
Who this helps: This benefits doctors and researchers studying diabetes and insulin sensitivity.
Ramipril increases the protein level of skeletal muscle IRS-1 and alters protein tyrosine phosphatase activity in spontaneously hypertensive rats.
2000
Naunyn-Schmiedeberg's archives of pharmacology
Krützfeldt J, Raasch W, Klein HH
Plain English This study examined how the drug ramipril affects insulin sensitivity in spontaneously hypertensive rats. Researchers found that after 12 weeks of treatment, ramipril increased the levels of a protein called IRS-1 in muscle by about 31%, and it improved the body’s ability to process insulin in both muscle and liver tissues. These findings are important because they suggest that ramipril may help improve insulin sensitivity, which is beneficial for managing conditions like high blood pressure and diabetes.
Who this helps: This research benefits patients with high blood pressure and diabetes.